CPS ENERGY LAUNCHES REQUEST FOR PROPOSAL FOR 500 MW OF BATTERY STORAGE

Once the RFP is finalized,the utility will have secured more than 1,000 MW of battery storage capacity to serve the community CPS Energy has issued a Request for Proposal (RFP) to acquire up to 500 megawatts (MW) of additional battery storage. This latest RFP supports the utility's previously approved Vision 2027 Generation Plan, which aims […]

Decision Notice – CIRO Hearing Panel Dismisses Allegations Against Teymur Englesby and Cale Nishimura, Reaffirms its Initial Decision

Following a review by the British Columbia Securities Commission (BCSC) of the decision on liability in the matter of Teymur Englesby and Cale Nishimura, a Canadian Investment Regulatory Organization (CIRO) hearing panel under the Investment Dealer and Partially Consolidated Rules reviewed and reaffirmed its initial decision and dismissed the allegations against the Respondents. The hearing

GeeFi (GEE) Presale Approaches Phase 3, Reporting Major Investors Spike as 2M Tokens Remains

KINGSTOWN, St. Vincent and Grenadines, Dec. 15, 2025 (GLOBE NEWSWIRE) — GeeFi Tech issued a significant update regarding its ongoing token presale, announcing that fewer than 2 million tokens remain available before the project transitions into Phase 3. This critical threshold marks a pivotal moment for the ecosystem, signaling the imminent conclusion of the current

GeeFi (GEE) Presale Approaches Phase 3, Reporting Major Investors Spike as 2M Tokens Remains

GeeFi (GEE) Presale Approaches Phase 3, Reporting Major Investors Spike as 2M Tokens Remains GlobeNewswire December 15, 2025 KINGSTOWN, St. Vincent and Grenadines, Dec. 15, 2025 (GLOBE NEWSWIRE) — GeeFi Tech issued a significant update regarding its ongoing token presale, announcing that fewer than 2 million tokens remain available before the project transitions into Phase

Roche receives FDA approval for first diagnostic tests to identify HER2-positive metastatic breast cancer patients eligible for ENHERTU

— FDA expands labels forRoche's PATHWAY HER2 (4B5) test* and VENTANA HER2 Dual ISH DNA Probe Cocktail, which can now be used to identify HER2-positive metastatic breast cancer patients that could be eligible for ENHERTU. — Roche's PATHWAY HER2 (4B5) test is the only test approved to identify all levels of HER2 expression. — Roche's

Levi & Korsinsky Helps Shareholders SueWallSt After Freeport-McMoRan Inc. Stock Drops

NEW YORK, NY / ACCESS Newswire / December 15, 2025 / – SueWallSt: Class Action Filed Against Freeport-McMoRan Inc. – Contact Levi & Korsinsky A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities fraud between February 15, 2022 and September 24, 2025. If you suffered

Notice – INTERNET SCIENCES INC. and CNSX MARKETS INC. and ONTARIO SECURITIES COMMISSION, File No. 2025-29

The Tribunal issued an Order in the above-named matter. A copy of the Order dated December 12, 2025, Reasons for Decision dated December 1, 2025 and Confidential Order dated December 3, 2025 are available at capitalmarketstribunal.ca Registrar, Governance & Tribunal Secretariat Ontario Securities Commission Subscribe to notices and other alerts from the Capital Markets Tribunal:

Investors SueWallSt as Inspire Medical Systems, Inc. Faces Securities Fraud Allegations

NEW YORK, NY / ACCESS Newswire / December 15, 2025 / – SueWallSt: Class Action Filed Against Inspire Medical Systems, Inc. – Contact Levi & Korsinsky A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities fraud between August 6, 2024 and August 4, 2025. If

Scroll to Top